$5.89
-0.16-2.64%
At close: -
$5.96
0.071.19%
After Hours: 7:53 PM EDT
Comments
Loading...
Altimmune Insider Trading Activity | NASDAQ:ALT | Benzinga
Track the latest Altimmune insider trading activity. Stay informed on recent buys, sells, and market impact for Altimmune stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Altimmune Inc Insiders Doing?
At Altimmune Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 11.00K shares for a total value of $57.78K.
Notable Recent Insider Buys and Sales
- On March 14, 2025, GREGORY WEAVER, the company's CHIEF FINANCIAL OFFICER purchased 10K shares for $5.2 each.
- On March 18, 2025, Catherine Sohn, the company's DIRECTOR purchased 1K shares for $5.78 each.
Ownership Statistics for Altimmune Inc
Shares Outstanding
71.125M
Insider Shares Owned
5.367M
Insider Percentage Owned
7.55%
Institutional Shares Held
25.869M
Institutional Percentage Held
33.6%
| Mar 18, 2025 | Catherine Sohn | DIRECTOR | 1.00K | $5.78 | $5.78K | BUY | ∞ | 1.00K | Mar 17 | View |
| Mar 14, 2025 | GREGORY WEAVER | CHIEF FINANCIAL OFFICER | 10.00K | $5.20 | $52.00K | BUY | ∞ | 10.00K | Mar 13 | View |
| Aug 20, 2024 | David Drutz | DIRECTOR | 25.74K | $4.73 | -$4.17K | SELL-OPTIONS | 86.42% | 55.52K | Aug 19 | View |
| Aug 15, 2023 | David Drutz | DIRECTOR | 300.00 | $2.88 | $862.50 | BUY | 1.02% | 29.79K | Aug 15 | View |
| Jul 06, 2023 | JOHN GILL | DIRECTOR | -2.71K | $15.00 | -$40.71K | SELL | -49.48% | 2.77K | Aug 12 | View |
| Mar 27, 2023 | David Drutz | DIRECTOR | 9.00K | $4.27 | $38.43K | BUY | 43.94% | 29.48K | Mar 23 | View |
| Mar 24, 2023 | Richard Eisenstadt as Attorney-in-Fact | CHIEF FINANCIAL OFFICER | 10.00K | $4.31 | $43.14K | BUY | 83.26% | 22.01K | Mar 24 | View |
| Mar 23, 2023 | Scott Matthew Harris | CHIEF MEDICAL OFFICER | 10.00K | $4.22 | $42.20K | BUY | 42.90% | 33.31K | Mar 23 | View |
| Dec 22, 2022 | Wayne Pisano | DIRECTOR | 0.00 | $8.81 | -$248.27K | SELL-OPTIONS | 0.00% | 8.50K | Dec 22 | View |
| Sep 01, 2022 | Vipin Garg | PRESIDENT AND CEO | -23.01K | $19.88 | -$457.27K | SELL | -8.86% | 236.80K | Aug 30 - Aug 31 | View |
| Aug 12, 2022 | Vipin Garg | PRESIDENT AND CEO | -15.00K | $15.06 | -$225.89K | SELL | -5.46% | 259.80K | Aug 12 | View |
| Jul 05, 2022 | Scot Roberts | CHIEF SCIENTIFIC OFFICER | -9.39K | $7.45 | -$365.46K | SELL | -53.03% | 8.32K | Jul 01 - Jul 05 | View |
| Jun 30, 2022 | Scot Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $7.30 | -$51.34K | SELL-OPTIONS | 0.00% | 17.71K | Jun 29 | View |
| Jun 28, 2022 | Scot Roberts | CHIEF SCIENTIFIC OFFICER | 0.00 | $7.07 | -$368.50K | SELL-OPTIONS | 0.00% | 17.71K | Jun 27 | View |
| Jun 28, 2022 | Diane Jorkasky | DIRECTOR | 0.00 | $7.45 | -$151.47K | SELL-OPTIONS | 0.00% | 0.00 | Jun 27 | View |
| Jun 16, 2022 | David Drutz | DIRECTOR | 1.00K | $8.00 | $8.00K | BUY | 5.17% | 20.34K | Jun 15 | View |
| May 25, 2022 | David Drutz | DIRECTOR | 1.20K | $4.50 | $5.40K | BUY | 6.61% | 19.34K | May 24 | View |
| Mar 02, 2022 | Scott Matthew Harris | CHIEF MEDICAL OFFICER | 0.00 | $4.72 | -$167.96K | SELL-OPTIONS | 0.00% | 11.54K | Feb 28 | View |
| Mar 01, 2021 | Philip Hodges | DIRECTOR | -6.00K | $16.08 | -$96.48K | SELL | -18.42% | 26.58K | Mar 01 | View |
| Dec 11, 2020 | Klaus Schafer | — | 2.00K | $11.99 | $23.98K | PURCHASE | 28.99% | 8.90K | Dec 10 | View |
| Dec 02, 2020 | Philip Hodges | — | -3.73K | $12.51 | -$46.61K | SELL | -17.27% | 17.85K | Nov 30 - Dec 01 | View |
| Dec 02, 2020 | JOHN GILL | — | -8.43K | $11.92 | -$100.43K | SELL | -42.93% | 11.20K | Nov 30 | View |
| Nov 13, 2020 | Klaus Schafer | — | -10.15K | $9.91 | -$100.59K | SELL | -59.53% | 6.90K | Nov 12 | View |
| Nov 13, 2020 | Wayne Pisano | — | -10.35K | $9.90 | -$102.48K | SELL | -54.92% | 8.50K | Nov 12 | View |
| Nov 13, 2020 | Scott Matthew Harris | — | -4.01K | $10.02 | -$40.23K | SELL | -49.67% | 4.07K | Nov 12 | View |
| Jun 15, 2020 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners II LPVHCP CoInvestment Holdings II LLCVHCP Management II LLCBong KohNimish Shah | — | 1.50M | $7.54 | $11.31M | PURCHASE | 50.00% | 4.50M | Jun 15 | View |
| May 28, 2020 | Venrock Healthcare Capital Partners III LPVHCP CoInvestment Holdings III LLCVHCP Management III LLCVenrock Healthcare Capital Partners II LPVHCP CoInvestment Holdings II LLCVHCP Management II LLCBong KohNimish Shah | — | 1.30M | $8.74 | $11.40M | PURCHASE | 76.85% | 3.00M | May 26 - May 28 | View |
| May 18, 2020 | VELOCITY PHARMACEUTICAL HOLDINGS LLC | — | -200.00K | $4.79 | -$957.10K | SELL | -10.60% | 1.69M | May 14 - May 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.